Cryoport officer Mark Sawicki proposes $199K share sale

The listed acquisition entries identify restricted stock vesting under a registered plan, with dates ranging from August 11, 2021, to March 22, 2024.

Available on EDGAR 11/10/2026 - 05:14 PM EST Accepted by SEC EDGAR 11/10/2026 - 05:13 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Cryoport, Inc. officer Mark Sawicki reported a proposed sale of 10,000 common shares, with an aggregate market value of $199,261 and an approximate sale date of November 10, 2026.

Key Figures

Proposed sale: 10,000 common shares Aggregate market value: $199,261 Shares outstanding: 50,700,429 shares

3 metrics

Proposed sale 10,000 common shares Approximate sale date: November 10, 2026

Aggregate market value $199,261 Securities proposed for sale

Shares outstanding 50,700,429 shares Issuer information

Key Terms

Restricted Stock Vesting Under a Registered Plan, Aggregate Market Value, Number of Shares or Other Units Outstanding

3 terms

Restricted Stock Vesting Under a Registered Plan financial

"Restricted Stock Vesting Under a Registered Plan"

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Number of Shares or Other Units Outstanding financial

"Number of Shares or Other Units Outstanding"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CYRX shares does Mark Sawicki plan to sell?

Mark Sawicki, an officer of Cryoport, reported a proposed sale of 10,000 common shares with an aggregate market value of $199,261, for an approximate sale date of November 10, 2026. Morgan Stanley Smith Barney LLC is named as broker.

How did Mark Sawicki acquire the CYRX shares he plans to sell?

The listed acquisition entries identify restricted stock vesting under a registered plan, acquired from the issuer. The entries include acquisitions from August 11, 2021, through March 22, 2024.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001848218
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CRYOPORT, INC.
SEC File Number	001-34632
Address of Issuer	112 Westwood Place, Suite 350 Brentwood TENNESSEE 37027
Phone	(949) 470-2300
Name of Person for Whose Account the Securities are To Be Sold	MARK SAWICKI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	199261.00	50700429	11/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/22/2024	Restricted Stock Vesting Under a Registered Plan	Issuer			1247	03/22/2024	Not Applicable
Common	09/08/2023	Restricted Stock Vesting Under a Registered Plan	Issuer			1000	09/09/2023	Not Applicable
Common	03/09/2023	Restricted Stock Vesting Under a Registered Plan	Issuer			1191	03/09/2023	Not Applicable
Common	03/09/2024	Restricted Stock Vesting Under a Registered Plan	Issuer			1248	03/09/2024	Not Applicable
Common	03/09/2022	Restricted Stock Vesting Under a Registered Plan	Issuer			1257	03/09/2022	Not Applicable
Common	03/14/2023	Restricted Stock Vesting Under a Registered Plan	Issuer			1252	03/14/2023	Not Applicable
Common	08/11/2021	Restricted Stock Vesting Under a Registered Plan	Issuer			2805	08/11/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark William Sawicki
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)